We are live on ! Find out more
CORV

Correvio Pharma Corp. Ordinary Shares (Canada)
CORV

Delisted

CORV was delisted on the 26th of May, 2020.

32 hedge funds and large institutions have $68.3M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2015 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

44% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 9

9% more capital invested

Capital invested by funds: $62.8M → $68.3M (+$5.49M)

7% more funds holding

Funds holding: 3032 (+2)

53% less call options, than puts

Call options by funds: $297K | Put options by funds: $636K

Holders
32
Holders Change
+2
Holders Change %
+6.67%
% of All Funds
0.85%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
13
Reduced
9
Closed
4
Calls
$297K
Puts
$636K
Net Calls
-$339K
Net Calls Change
-$361K

CORV Hedge Fund Activity: Q1 2015 in Review

32 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) for Q1 2015, worth a combined $68.3M — up 8.7% from $62.8M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new CORV positions and 4 closed out — a net gain of 2 holders — while 13 added to existing stakes and 9 trimmed.

The largest buyer was Westfield Capital Management, adding an estimated $6.85M. The largest seller was Fortress Investment Group, exiting entirely with an estimated $8.23M sold.

  • 32 institutional investors held Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) as of Q1 2015, up from 30 in Q4 2014.
  • Funds reported $68.3M of Correvio Pharma Corp. Ordinary Shares (Canada) stock for Q1 2015, up 8.7% quarter-over-quarter.
  • 6 funds opened new Correvio Pharma Corp. Ordinary Shares (Canada) positions in Q1 2015 and 4 closed out, a net change of +2 holders.
  • The largest Correvio Pharma Corp. Ordinary Shares (Canada) buyer in Q1 2015 was Westfield Capital Management, an estimated $6.85M added.
  • The largest Correvio Pharma Corp. Ordinary Shares (Canada) seller in Q1 2015 was Fortress Investment Group, an estimated $8.23M sold.

Based on aggregated 13F filings for Q1 2015.